Modelling Exposure-Driven Adverse Event Time Courses in Oncology Exemplified by Afatinib
CPT: Pharmacometrics and Systems Pharmacology - United States
doi 10.1002/psp4.12384
Full Text
Open PDFAbstract
Available in full text
Date
February 27, 2019
Authors
Publisher
Wiley